These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35521968)

  • 1. The chaperone Clusterin in neurodegeneration-friend or foe?
    Yuste-Checa P; Bracher A; Hartl FU
    Bioessays; 2022 Jul; 44(7):e2100287. PubMed ID: 35521968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation.
    Wojtas AM; Carlomagno Y; Sens JP; Kang SS; Jensen TD; Kurti A; Baker KE; Berry TJ; Phillips VR; Castanedes MC; Awan A; DeTure M; De Castro CHF; Librero AL; Yue M; Daughrity L; Jansen-West KR; Cook CN; Dickson DW; Petrucelli L; Fryer JD
    Acta Neuropathol Commun; 2020 Dec; 8(1):210. PubMed ID: 33261653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model.
    Yuste-Checa P; Trinkaus VA; Riera-Tur I; Imamoglu R; Schaller TF; Wang H; Dudanova I; Hipp MS; Bracher A; Hartl FU
    Nat Commun; 2021 Aug; 12(1):4863. PubMed ID: 34381050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Annadurai N; De Sanctis JB; Hajdúch M; Das V
    Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.
    Braak H; Del Tredici K
    Cold Spring Harb Perspect Biol; 2016 Nov; 8(11):. PubMed ID: 27580631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease.
    Duyckaerts C; Clavaguera F; Potier MC
    Curr Opin Neurol; 2019 Apr; 32(2):266-271. PubMed ID: 30724769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
    Li X; James S; Lei P
    J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
    Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
    FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.
    Hasegawa M
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial contributions to neurodegeneration in tauopathies.
    Leyns CEG; Holtzman DM
    Mol Neurodegener; 2017 Jun; 12(1):50. PubMed ID: 28662669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.
    Ramachandran G; Udgaonkar JB
    Biochemistry; 2013 Jun; 52(24):4107-26. PubMed ID: 23721410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azure C Targets and Modulates Toxic Tau Oligomers.
    Lo Cascio F; Kayed R
    ACS Chem Neurosci; 2018 Jun; 9(6):1317-1326. PubMed ID: 29378132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
    Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.